| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| N Wioland, G Rudolf, N Bonaventur. Electrooculographic and electroretinographic study in the chicken after dopamine and haloperidol. Documenta ophthalmologica. Advances in ophthalmology. vol 75. issue 2. 1991-03-04. PMID:2276318. |
electrooculographic and electroretinographic study in the chicken after dopamine and haloperidol. |
1991-03-04 |
2023-08-11 |
chicken |
| N Wioland, G Rudolf, N Bonaventur. Electrooculographic and electroretinographic study in the chicken after dopamine and haloperidol. Documenta ophthalmologica. Advances in ophthalmology. vol 75. issue 2. 1991-03-04. PMID:2276318. |
the implication of dopamine in the modulation of the standing potential of the eye was tested in the chicken through an indirect electrooculographic method and direct current electroretinogram (erg) recording after haloperidol, a mixed d1-d2 antagonist. |
1991-03-04 |
2023-08-11 |
chicken |
| J Lappalainen, J Hietala, M Koulu, E Syvälaht. Neurochemical effects of chronic co-administration of ritanserin and haloperidol: comparison with clozapine effects. European journal of pharmacology. vol 190. issue 3. 1991-02-28. PMID:2125564. |
the effects of chronic treatment with clozapine (20 mg/kg per day), ritanserin (0.5 mg/kg per day), haloperidol (0.5 mg/kg per day), or the combination of haloperidol and ritanserin, on dopamine (da) and serotonin (5-ht) metabolism were studied. |
1991-02-28 |
2023-08-11 |
Not clear |
| H H Berendsen, C L Broekkamp, A M Van Delf. Antagonism of 8-OH-DPAT-induced behaviour in rats. European journal of pharmacology. vol 187. issue 1. 1991-02-28. PMID:2148726. |
however, 8-oh-dpat-induced llr could be antagonised by pindolol, spiperone, spiroxatrine and nan-190, but not by the beta 1-adrenoceptor antagonist metoprolol, the beta 2-adrenoceptor antagonist butoxamine or the dopamine antagonist haloperidol. |
1991-02-28 |
2023-08-11 |
rat |
| B Glenthøj, R Hemmingsen, P Allerup, T G Bolwi. Intermittent versus continuous neuroleptic treatment in a rat model. European journal of pharmacology. vol 190. issue 3. 1991-02-28. PMID:2272366. |
seventy-five rats were treated discontinuously or continuously with the predominantly dopamine d2 receptor blocker haloperidol or the combined dopamine d1/d2 receptor blocker zuclopenthixol for 15 weeks. |
1991-02-28 |
2023-08-11 |
rat |
| J Z Fields, J M Lee, J H Gordon, L J Wichlinski, R F Ritzman. The effects of cyclo(leucyl-glycyl) on nigrostriatal dopaminergic supersensitivity--inhibition of apomorphine-induced climbing. Neuropeptides. vol 16. issue 4. 1991-02-28. PMID:2274115. |
in a previous study we showed that cyclo(leu-gly) (clg) prevents the behavioural supersensitivity induced in the mesolimbic dopamine (da) tract (in mice) by chronic haloperidol (hal). |
1991-02-28 |
2023-08-11 |
mouse |
| J Ichikawa, H Y Meltze. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens. The Journal of pharmacology and experimental therapeutics. vol 256. issue 1. 1991-02-22. PMID:1703232. |
differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens. |
1991-02-22 |
2023-08-11 |
rat |
| J Ichikawa, H Y Meltze. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens. The Journal of pharmacology and experimental therapeutics. vol 256. issue 1. 1991-02-22. PMID:1703232. |
the differential effects of haloperidol (hal) and clozapine (cloz) on dopamine (da) release and metabolism (dihydroxyphenylacetic acid levels) in striatum and nucleus accumbens (accumbens) of freely moving rats were investigated using microdialysis. |
1991-02-22 |
2023-08-11 |
rat |
| L P Xing, C Balaban, J Seaton, J Washington, G Kauffma. Mesolimbic dopamine mediates gastric mucosal protection by central neurotensin. The American journal of physiology. vol 260. issue 1 Pt 1. 1991-02-21. PMID:1899007. |
these effects were blocked by pretreatment with the dopamine (da) receptor antagonist, haloperidol (hal; 0.5 microgram/side) given directly into nacb. |
1991-02-21 |
2023-08-11 |
Not clear |
| B H Westerink, J B De Vrie. Effect of precursor loading on the synthesis rate and release of dopamine and serotonin in the striatum: a microdialysis study in conscious rats. Journal of neurochemistry. vol 56. issue 1. 1991-02-15. PMID:1898966. |
when the precursor administration was repeated in rats in which the release of dopamine was stimulated by haloperidol pretreatment, again no effect was seen on the release of dopamine. |
1991-02-15 |
2023-08-11 |
rat |
| I S Login, S I Kuan, A M Judd, R M MacLeo. Regulation of the intracellular calcium concentration in MMQ pituitary cells by dopamine and protein kinase C. Cell calcium. vol 11. issue 8. 1991-02-08. PMID:1702364. |
dopamine had no detectable independent effect, but significantly inhibited the rise in intracellular calcium mediated by activation of voltage-dependent calcium channels; this dopaminergic action was prevented by haloperidol. |
1991-02-08 |
2023-08-11 |
Not clear |
| P dos S Rodrigues, J E Dowlin. Dopamine induces neurite retraction in retinal horizontal cells via diacylglycerol and protein kinase C. Proceedings of the National Academy of Sciences of the United States of America. vol 87. issue 24. 1991-02-07. PMID:2263620. |
the effects of dopamine are blocked by haloperidol and sch 23390, a d1 antagonist, but not by sulpiride, a d2 antagonist. |
1991-02-07 |
2023-08-11 |
Not clear |
| J Kulkarni, N A Keks, G Stuart, B Mackie, I H Minas, B S Singh, D L Copolo. Relationship of psychotic symptoms to haloperidol-stimulated prolactin release. Acta psychiatrica Scandinavica. vol 82. issue 4. 1991-01-28. PMID:2260479. |
prolactin (prl) response to a single dose of intravenous haloperidol (0.5 mg) was measured as a marker of tuberoinfundibular dopamine (tida) activity in 24 neuroleptic-free, male, psychotic patients. |
1991-01-28 |
2023-08-11 |
Not clear |
| S A Parashos, C Marin, P Barone, V Kapitzoglou-Logothetis, T N Chas. Effect of chronic D-1 and/or D-2 dopamine antagonist treatment on SKF 38393-induced non-stereotyped grooming. Psychopharmacology. vol 102. issue 3. 1991-01-17. PMID:2251338. |
the effects of chronic d-1 and/or d-2 dopamine (da) receptor blockade on a putative d-1 da receptor-mediated behavioral function was studied in rats treated for 21 days with the selective d-1 antagonist sch 23390, the predominantly d-2 antagonist haloperidol, or the combination of both drugs at the same daily doses. |
1991-01-17 |
2023-08-11 |
rat |
| T Ljungberg, M Enquis. Effects of dopamine D-1 and D-2 antagonists on decision making by rats: no reversal of neuroleptic-induced attenuation by scopolamine. Journal of neural transmission. General section. vol 82. issue 3. 1991-01-15. PMID:1979001. |
the effects of the dopamine (da) d-1 antagonist sch 23390 and the d-2 antagonists haloperidol and sulpiride on decision making in thirsty rats were investigated. |
1991-01-15 |
2023-08-11 |
rat |
| R E See, A W Toga, G Elliso. Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats. Journal of neural transmission. General section. vol 82. issue 2. 1990-12-20. PMID:1977417. |
these data suggest that persisting alterations in receptor binding are primarily seen in dopamine d2 and gaba receptors after withdrawal from chronic administration of haloperidol but not the atypical neuroleptics, clozapine and raclopride. |
1990-12-20 |
2023-08-11 |
rat |
| H Hall, I Wedel, C Halldin, J Kopp, L Fard. Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes. Journal of neurochemistry. vol 55. issue 6. 1990-12-20. PMID:1977888. |
there was an approximate overall similarity between the inhibition constants for five dopamine antagonists, chlorpromazine, haloperidol, raclopride, remoxipride, and nmsp, when using either radioligand. |
1990-12-20 |
2023-08-11 |
human |
| S J O'Dell, G J La Hoste, C B Widmark, R M Shapiro, S G Potkin, J F Marshal. Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain. Synapse (New York, N.Y.). vol 6. issue 2. 1990-12-20. PMID:2237777. |
chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain. |
1990-12-20 |
2023-08-11 |
rat |
| N Pradhan, A S Arunasmith. Changes in the sensitivities of dopamine receptors to chronic treatment with imipramine & haloperidol in rats. The Indian journal of medical research. vol 92. 1990-12-19. PMID:2228076. |
changes in the sensitivities of dopamine receptors to chronic treatment with imipramine & haloperidol in rats. |
1990-12-19 |
2023-08-11 |
rat |
| S O Ogren, L Florvall, H Hall, O Magnusson, K Angeby-Mölle. Neuropharmacological and behavioural properties of remoxipride in the rat. Acta psychiatrica Scandinavica. Supplementum. vol 358. 1990-12-14. PMID:1978483. |
remoxipride blocks dopamine agonist-induced effects in the rat, mediated by dopamine d2 receptors with an in-vivo potency less than that of haloperidol but greater than that of chlorpromazine, thioridazine, and sulpiride. |
1990-12-14 |
2023-08-11 |
rat |